NCT06535607
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06535607
Title Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors (eVOLVE-02)
Acronym eVOLVE-02
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BRA

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING Los Angeles California 90025 United States Details
Research Site NOT_YET_RECRUITING Baltimore Maryland 21201 United States Details
Research Site NOT_YET_RECRUITING Stony Brook New York 11794 United States Details
Research Site NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
Research Site NOT_YET_RECRUITING Ijuí 98700-000 Brazil Details
Research Site NOT_YET_RECRUITING Londrina 86015-520 Brazil Details
Research Site NOT_YET_RECRUITING São Caetano do Sul 09541-270 Brazil Details
Research Site NOT_YET_RECRUITING Vitória 29043-260 Brazil Details
Research Site RECRUITING Beijing 100142 China Details
Research Site RECRUITING Beijing 100730 China Details
Research Site RECRUITING Beijing CN-100730 China Details
Research Site RECRUITING Bengbu 233004 China Details
Research Site WITHDRAWN Changchun 130021 China Details
Research Site NOT_YET_RECRUITING Changsha 410003 China Details
Research Site ACTIVE_NOT_RECRUITING Changsha 410008 China Details
Research Site NOT_YET_RECRUITING Changsha 410008 China Details
Research Site ACTIVE_NOT_RECRUITING Changsha 410013 China Details
Research Site ACTIVE_NOT_RECRUITING Chengdu 610041 China Details
Research Site NOT_YET_RECRUITING Chengdu 610072 China Details
Research Site RECRUITING Chongqing 400030 China Details
Research Site RECRUITING Dongguan 523009 China Details
Research Site COMPLETED Fuzhou 350011 China Details
Research Site NOT_YET_RECRUITING Fuzhou 350014 China Details
Research Site ACTIVE_NOT_RECRUITING Hangzhou 310022 China Details
Research Site RECRUITING Hangzhou 310022 China Details
Research Site RECRUITING Jining 272029 China Details
Research Site RECRUITING Kunming 650118 China Details
Research Site RECRUITING Nanchang 330006 China Details
Research Site ACTIVE_NOT_RECRUITING Nanning 530021 China Details
Research Site RECRUITING Nanning 530021 China Details
Research Site NOT_YET_RECRUITING Shandong 250117 China Details
Research Site RECRUITING Shandong China Details
Research Site ACTIVE_NOT_RECRUITING Shandong China Details
Research Site ACTIVE_NOT_RECRUITING Shanghai 200120 China Details
Research Site RECRUITING Shanghai 200120 China Details
Research Site RECRUITING Shenyang 110004 China Details
Research Site ACTIVE_NOT_RECRUITING Tianjin 300060 China Details
Research Site RECRUITING Tianjin 300060 China Details
Research Site RECRUITING Wuhan 430022 China Details
Research Site ACTIVE_NOT_RECRUITING Wuhan 430022 China Details
Research Site RECRUITING Wuhan 430040 China Details
Research Site RECRUITING Wuhan 430048 China Details
Research Site RECRUITING Wuhan 430079 China Details
Research Site NOT_YET_RECRUITING Wuhou District 610041 China Details
Research Site RECRUITING Namdong-gu 21565 South Korea Details
Research Site RECRUITING Seoul 03722 South Korea Details
Research Site NOT_YET_RECRUITING Taichung Taiwan Details
Research Site NOT_YET_RECRUITING Taipei 112 Taiwan Details
Research Site NOT_YET_RECRUITING Hanoi 100000 Vietnam Details
Research Site NOT_YET_RECRUITING Ho Chi Minh City 700000 Vietnam Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field